Rituximab in the Treatment of Scleritis and Non-Infectious Orbital Inflammation

Summary

The purpose of this study is to assess the safety and tolerability of Rituximab in refractory scleritis and non-infectious orbital inflammation.

Timeline

Start

2007-01

Primary completion

2011-03

Completion

2011-03

Publications

• Suhler EB, Lim LL, Beardsley RM, Giles TR, Pasadhika S, Lee ST, de Saint Sardos A, Butler NJ, Smith JR, Rosenbaum JT. Rituximab therapy for refractory orbital inflammation: results of a phase 1/2, dose-ranging, randomized clinical trial. JAMA Ophthalmol. 2014 May;132(5):572-8. doi: 10.1001/jamaophthalmol.2013.8179.

Drugs

Indications